Sweden Ghana Medical Centre

What Sweden Ghana Medical Centre does

Sweden Ghana Medical Centre (SGMC) is a privately-owned comprehensive oncology centre located at East Legon Hills in Accra, Ghana. Established in 2007 and treating patients since 2011, SGMC operates as West Africa's leading private cancer treatment facility, providing integrated radiotherapy, chemotherapy, brachytherapy, and diagnostic imaging under one roof. Its service mix targets breast, cervical, prostate, head and neck, gastrointestinal, CNS, and sarcoma cancers, supported by consultation, screening (including the My Life Check executive programme), second-opinion, nutrition, and post-treatment follow-up services.

The centre's technology stack centres on Elekta linear accelerators (including the multi-leaf dual-energy LINAC with IMRT/3D conformal capability and the Elekta Infinity Version LINAC), a 3D treatment planning system, an on-site oncology pharmacy with laminar flow cytotoxic preparation, and a nuclear medicine facility comprising a PET-CT Scanner and Cyclotron — the first such installation in West Africa and the 80th globally, commissioned in May 2026. Revenue is generated on a fee-for-service, quote-based model: each patient receives a personalised treatment package price covering specialist consultations, diagnostic imaging, dose planning by medical physicists, drugs, and radiation protocols. Patient mix is roughly 60% Ghanaian and 40% cross-border, drawn from Nigeria, Côte d'Ivoire, Burkina Faso, Togo, Sierra Leone, and Liberia via an established referral network with bilingual English-French case management and full medical-tourism logistics.

The facility is primarily owned by Swedish-domiciled Global Medical Investments (GMI-AB), an investment vehicle formed in 2009 by Swedfund (Sweden's development finance institution) in partnership with Elekta and Ghanaian investors, which has deployed over $20M of capital. Operations are run by an African management team under CEO Joshua Tetteh, with Dr. Clement Egyin Edusa serving as Medical Director and Dr. Olof Stahl as Clinical Medical Director. Research and training partnerships are in place with the Ghana Atomic Energy Commission and other West African cancer centres, and a philanthropic arm (Sweden Ghana Cancer Foundation) subsidises treatment costs for patients unable to pay.

Name

Sweden Ghana Medical Centre

Legal name

Sweden Ghana Medical Centre

Website

https://sgmccancercentre.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Sweden Ghana Medical Centre is a privately-owned comprehensive oncology centre in Accra, Ghana, offering radiotherapy, chemotherapy, brachytherapy, and diagnostic imaging — including West Africa's first PET-CT Scanner and Cyclotron — to local and regional cancer patients across seven West African countries.

Ownership category

akta.pro rank

Product category

Oncology and Cancer Treatment Services

NAICS

Diagnostic Imaging Centers (621512), Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industry

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

Keywords

• Cancer treatment services
• Radiation oncology
• Medical imaging services
• Chemotherapy treatment
• Oncology diagnostics

Headquarters

HQ city

Accra

HQ country

Ghana

HQ region

Africa

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Cancer Treatment Services: Fee-for-service model for radiotherapy, chemotherapy, brachytherapy, and diagnostic imaging. Treatment costs vary based on cancer type, treatment protocol, drug selection, frequency and duration of treatment. Payment accepted via direct wire transfers, cash, cheques, and Visa.
2. Medical Consultation Services: Oncology specialist consultations and second opinion services billed per visit
3. Cancer Screening Services: Preventive screening services including the My Life Check program for early cancer detection

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

SGMC is a comprehensive private oncology centre delivering cancer diagnosis and treatment services including radiotherapy (external beam and brachytherapy), chemotherapy, and advanced diagnostic imaging (PET-CT, CT, MRI). It serves both local Ghanaian patients and medical tourism patients from across West Africa, with personalized treatment protocols, on-site oncology pharmacy, case management, and post-treatment follow-up under one roof.

Product overview

Sweden Ghana Medical Centre operates as a comprehensive oncology centre offering integrated cancer care services. The facility provides a unified treatment platform combining diagnostic imaging (PET-CT, CT, MRI, Cyclotron), treatment services (radiotherapy using Elekta linear accelerators, chemotherapy, brachytherapy), and patient support services (case management, medical tourism packages, nutrition services, post-treatment care). The centre serves as West Africa's leading private cancer care facility, offering both local and international patients access to European-standard oncology treatment.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiotherapy Radiotherapy treatment using radiation to kill cancer cells, including external beam radiotherapy and internal radiotherapy (brachytherapy). Uses advanced linear accelerator technology with 3D conformal treatment planning.
• Chemotherapy Treatment using cytotoxic drugs to kill cancer cells, administered in chemotherapy suites with fully functional infusion pumps. Includes preparation in laminar airflow biological safety cabinet.
• Brachytherapy (Curietherapy) Internal radiotherapy using radioactive seeds implanted directly into tumor sites to kill cancer cells. Uses gold markers for internal beam guidance.
• Nuclear Medicine Facility (PET-CT Scanner and Cyclotron) State-of-the-art nuclear medicine facility including PET-CT Scanner and Cyclotron for advanced cancer diagnostics and treatment. First of its kind in West Africa and 80th in the world.
• CT Scan Computed Tomography imaging using special X-ray machines producing detailed 3D images of the body for diagnosis and treatment planning.
• MRI Magnetic Resonance Imaging using magnets instead of ionizing radiation to produce detailed images of soft tissues, particularly useful for brain, muscles, and vertebrae.
• Consultation Services Oncology and general consultation services including medical evaluation and personalized consultation with oncologists, five days per week with on-call oncologist availability.
• Screening Services Cancer screening services including My Life Check program for executives and individuals aged 40+ to assess cancer risks and health trends.
• Diagnostic Services Cancer detection and diagnosis including blood tests, tumor marker detection, and biopsy procedures for confirmed cancer diagnosis.
• Case Management 24/7 case management coordination including logistical support, medical records management, treatment scheduling, and communication between patients, families, and clinical teams.
• Medical Tourism Services Comprehensive medical tourism packages for foreign patients including airport pickup, accommodation arrangements, transport during treatment, and French-speaking coordinators for Francophone patients.
• Oncology Pharmacy On-site pharmacy specializing in oncology medications with cytotoxic drug handling capabilities, sourced from FDA-approved pharmaceutical suppliers.
• Nutrition Services On-site nutritionist providing dietary recommendations and specialized nutrition plans for cancer patients during treatment.
• Second Opinion Service Second opinion consultations for cancer diagnosis and treatment options, evaluating medical history and conducting diagnostic testing to confirm or supplement treatment approaches.
• Post-Treatment Support One-year post-treatment follow-up including periodic health reviews by oncologists, regular contact from case managers, and ongoing health information.

Quantifiable outcome

• Average time to start treatment: 2-5 days
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core, significant and minor.

• Ghana Atomic Energy Commission (GAEC)coreStrategic or Co-development Partner · 10 July 2013SGMC signed a Memorandum of Understanding with GAEC to establish collaborative working relationship for teaching, training, and developing human resource in cancer research. SGMC makes its clinical facility and equipment available for training MPhil and PhD students in Medical Physics from GAEC's School of Nuclear and Allied Sciences (SNAS). The partnership enhances SGMC's reputation as a center of excellence for research and training in addition to patient treatment.
• Ghana National Association of Teachers (GNAT)significantStrategic or Co-development Partner · 6 June 2013GNAT donated GH¢100,000 to Sweden Ghana Cancer Foundation to support foundation initiatives for early treatment of cancer patients who cannot afford treatment costs and to educate the public on disease prevention. GNAT-LAS launched healthy lifestyle campaign including breast and cervical cancer screening. A formal agreement provides GNAT members access to all SGMC services including screening, CT scan, MRI, consultations, radiotherapy and chemotherapy at negotiated rates.
• ElektacoreTechnology or IntegrationElekta, as an innovator in equipment and software used to improve, prolong and save lives of people with cancer and brain disorders, partnered with GMI-AB and Swedfund to provide state-of-the-art radiotherapy equipment including the Infinity Linear Accelerator and treatment planning systems. SGMC uses Elekta equipment and benefits from ongoing technical support.
• Lakeshore Cancer Centre (Nigeria)minorStrategic or Co-development PartnerTwo oncology nurses from Lakeshore Cancer Centre in Nigeria visited SGMC for a week-long training in chemotherapy protocols. This represents a training collaboration where SGMC shares its expertise with other cancer centers in the region.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Others

• HCG Hospitals: India-based oncology hospital network referenced in SGMC's international pricing benchmarks ($800-$1,500 per radiotherapy fraction). Represents an offshore medical-tourism competitor SGMC positions against.
• Elekta: Swedish maker of linear accelerators and radiotherapy software that supplied SGMC's Elekta Infinity LINAC and is a financial partner. While primarily a vendor, Elekta's broader installed base across global cancer centers shapes the technology landscape SGMC operates in.
• Apollo Hospitals: Large Indian hospital chain cited in SGMC's pricing comparisons as a medical-tourism alternative. Represents the offshore destination SGMC competes against for West African patients seeking affordable cancer care.

Broad incumbents

• Netcare: Largest private hospital network in South Africa with oncology units. Historically the regional benchmark for advanced private cancer care to which West African patients are referred; sets the competitive ceiling on regional medical-tourism pricing.
• Korle Bu Teaching Hospital - National Centre for Radiotherapy and Nuclear Medicine: Ghana's leading public teaching hospital with an established radiotherapy and nuclear medicine unit. Provides the same core services (chemotherapy, radiotherapy) within Ghana but operates as part of a larger public hospital system rather than as a private specialist oncology center.

Regional players

• Kenyatta National Hospital - Oncology Unit: East Africa's leading public hospital with oncology services. Comparable as a sub-Saharan public academic oncology center, though geographically distinct from SGMC's West African footprint.
• Institut de Cancérologie de Dakar: Specialized cancer treatment institute in Senegal offering radiotherapy and chemotherapy in Francophone West Africa. Competes for the same Francophone patient pool that SGMC targets with its bilingual case management.

Direct peers

• NSIA-LUTH Cancer Centre: Public-private oncology centre in Lagos, Nigeria, providing radiotherapy, chemotherapy, and nuclear medicine. Competes directly for Nigerian referral patients in West Africa's regional oncology market.
• Marcelle Ruth Cancer Centre: Private comprehensive oncology center in Lagos, Nigeria, offering chemotherapy, radiotherapy, and diagnostics. Competes for West African private-pay and medical-tourism oncology patients with a similar premium positioning.
• Lakeshore Cancer Centre: Private oncology center in Lagos, Nigeria, offering chemotherapy and radiotherapy. Directly comparable as a regional private cancer-treatment competitor; SGMC has already trained Lakeshore nurses, evidencing the overlap.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sweden-ghana-medical-centre-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sweden Ghana Medical Centre